oleanolic acid has been researched along with Graft vs Host Disease in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Li, M; Murphy, WJ; Redelman, D; Sun, K; Welniak, LA | 1 |
Andreeff, M; Frolova, O; Konoplev, S; Konopleva, M; Kornblau, SM; Li, M; Ma, W; Murphy, WJ; Stephens, LC; Sun, K; Welniak, LA; Wilkins, DE | 1 |
2 other study(ies) available for oleanolic acid and Graft vs Host Disease
Article | Year |
---|---|
The triterpenoid CDDO-Me delays murine acute graft-versus-host disease with the preservation of graft-versus-tumor effects after allogeneic bone marrow transplantation.
Topics: Animals; Apoptosis; Bone Marrow Transplantation; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Colon; Female; Graft vs Host Disease; Graft vs Tumor Effect; Immunosuppressive Agents; Integrins; Leukemia, Myeloid, Acute; Liver; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oleanolic Acid; Spleen; Survival Analysis; T-Lymphocytes; Transplantation, Homologous; Tumor Necrosis Factor-alpha | 2010 |
The synthetic triterpenoid, CDDO, suppresses alloreactive T cell responses and reduces murine early acute graft-versus-host disease mortality.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Disease Models, Animal; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Lymphocyte Culture Test, Mixed; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oleanolic Acid; T-Lymphocytes; Transplantation, Homologous | 2007 |